Evia Bio is a life science innovation company focused on advancing the field of cryopreservation, particularly for the cell therapy market. The company offers a range of non-DMSO cryopreservation solutions that utilize all-natural organic compounds to maintain cell integrity during freezing processes. These solutions are developed under the guidance of Dr. Allison Hubel, a leading cryobiologist, and are designed to enhance the performance of cells while ensuring patient safety. Evia Bio's offerings include assessment services to evaluate existing protocols, as well as custom-fit improvements tailored to specific needs in cell therapy.

In addition to their cryopreservation solutions, Evia Bio fosters collaboration and knowledge sharing through initiatives like CryoConnect, which brings together thought leaders and practitioners in the field. They provide hands-on training workshops that cover essential topics such as cell enumeration and cryoprotectant formulation, catering to both novices and experienced professionals. By leveraging AI-driven, patented technologies, Evia Bio aims to revolutionize cryopreservation practices, ultimately unlocking the potential of life-saving therapies in clinical settings.

United States

Evia Bio™ is a life science innovation company enabling the growing cell therapy market. We provide new non-DMSO cryopreservation solutions developed by world-leading cryobiologist, Allison Hubel, PhD. We partner with cell therapy companies looking to advance their products to clinical trials and commercialization. Our solutions unlock the full potential of emerging life-saving therapies through the use of all-natural organic compounds to protect the integrity of cells during cryopreservation and patient safety at the point of care.

Please visit www.eviabio.com.

Evia Bio

Company Details